SCHEMBL6136796

SCHEMBL6136796

[CH2]C(=O)c1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.55
RECQL P46063 1/20 0.55
CA2 P00918 3/20 0.54
CA1 P00915 2/20 0.54
SMN1; SMN2 Q16637 3/20 0.52
ALDH1A1 P00352 2/20 0.52
POLB P06746 1/20 0.52
TYR P14679 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
ALOX5 P09917 2/20 0.51
PTGS1 P23219 2/20 0.51
PTGS2 P35354 2/20 0.51
GAA P10253 3/20 0.50
TDP1 Q9NUW8 1/20 0.50
GLRA3 O75311 1/20 0.50
GLRB P48167 1/20 0.50
TNFRSF1A P19438 1/20 0.47
MEN1 O00255 1/20 0.47
GALR3 O60755 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL47590 0.83 LMNA (0.55) LMNARECQLCA2CA1SMN1; SMN2
SCHEMBL8495448 0.82 ALOX5 (0.65) LMNARECQLCA2CA1SMN1; SMN2
SCHEMBL4448135 0.80 LMNA (0.56) LMNARECQLCA2CA1SMN1; SMN2
SCHEMBL47718 0.80 SMN1; SMN2 (0.59) LMNARECQLCA2CA1SMN1; SMN2
SCHEMBL227202 0.80 GLRA3 (0.63) LMNARECQLCA2CA1SMN1; SMN2
SCHEMBL5139534 0.80 CA2 (0.56) LMNARECQLCA2CA1SMN1; SMN2
SCHEMBL9355788 0.78 GLRA3 (0.61) LMNARECQLCA2CA1SMN1; SMN2
SCHEMBL8659247 0.78 GLRA3 (0.61) LMNARECQLCA2CA1SMN1; SMN2
Hydrochloric Acid SCHEMBL1943524 0.78 GLRA3 (0.61) LMNARECQLCA2CA1SMN1; SMN2
SCHEMBL4257166 0.78 LMNA (0.59) LMNARECQLCA2CA1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6007865-A FOR INHIBITING AND REVERSING NONENZYMATIC CROSS-LINKING (PROTEIN AGING), TREATING KIDNEY DAMAGE AND TREATING COMPLICATIONS OF DIABETES, PREVENTING FOOD SPOILAGE ALTEON INC. 1999-12-28 US claimed
EP-0059090-B1 3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL-SUBSTITUTED HETEROCYCLIC COMPOUNDS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1986-01-29 EP claimed
EP-0059090-A1 3,5-Di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1982-09-01 EP claimed
EP-0991654-B1 NOVEL 2-(IMINOMETHYL)AMINO-PHENYL DERIVATIVES, PREPARATION, APPLICATION AS MEDICINES AND COMPOSITIONS CONTAINING SAME SOD CONSEILS RECH APPLIC (FR) 2005-06-15 EP disclosed
EP-0991654-A1 NOVEL 2-(IMINOMETHYL)AMINO-PHENYL DERIVATIVES, PREPARATION, APPLICATION AS MEDICINES AND COMPOSITIONS CONTAINING SAME SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2000-04-12 EP disclosed
WO-1998058934-A1 NOVEL 2-(IMINOMETHYL)AMINO-PHENYL DERIVATIVES, PREPARATION, APPLICATION AS MEDICINES AND COMPOSITIONS CONTAINING SAME SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 1998-12-30 WO disclosed
EP-0059090-B1 3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL-SUBSTITUTED HETEROCYCLIC COMPOUNDS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1986-01-29 EP disclosed
EP-0059090-A1 3,5-Di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1982-09-01 EP disclosed